Tokyo, Japan

Keisuku Murayama

This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keisuku Murayama. Retrieved from https://idiyas.com/inventor/keisuku-murayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keisuku Murayama: Innovator in Chemical Derivatives

Introduction

Keisuku Murayama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of innovative chemical compounds. His work has led to the creation of a unique patent that showcases his expertise and creativity.

Latest Patents

Murayama holds a patent for Piperidine-spiro-hydantoin derivatives. This patent involves compounds characterized by the formula ##STR1##, wherein X represents either an oxygen atom or a sulfur atom, and n is an integer ranging from 1 to 4 inclusive. This innovation highlights his ability to explore complex chemical structures and their potential applications.

Career Highlights

Keisuku Murayama is associated with Sankyo Company, Limited, where he has been able to apply his knowledge and skills in a professional setting. His work at this esteemed company has allowed him to contribute to advancements in the pharmaceutical and chemical industries.

Collaborations

Murayama has collaborated with notable colleagues such as Syoji Moriyama and Takao Yoshioka. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment that encourages innovation.

Conclusion

Keisuku Murayama is a distinguished inventor whose work in chemical derivatives has made a significant impact. His patent for Piperidine-spiro-hydantoin derivatives exemplifies his innovative spirit and dedication to advancing the field of chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…